Meta-analysis of individual participant data: rationale, conduct, and reporting

The use of individual participant data instead of aggregate data in meta-analyses has many potential advantages, both statistically and clinically. Richard D Riley and colleagues describe the rationale for an individual participant data meta-analysis and outline how to conduct this type of study

[1]  S. Haque.  Ethics approval This study was conducted with the approval of the East London and City Health Authority Ethic Committee. Provenance and peer review Not commissioned; externally peer reviewed. , 2011 .

[2]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[3]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[4]  Yvonne Vergouwe,et al.  Prognosis and prognostic research: validating a prognostic model , 2009, BMJ : British Medical Journal.

[5]  P. Vedsted,et al.  [From science to practice]. , 2009, Ugeskrift for laeger.

[6]  Anne Whitehead,et al.  Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials , 2009, Clinical trials.

[7]  David J Spiegelhalter,et al.  A re-evaluation of random-effects meta-analysis , 2009, Journal of the Royal Statistical Society. Series A,.

[8]  Richard D Riley,et al.  Meta‐analysis of diagnostic test studies using individual patient data and aggregate data , 2008, Statistics in medicine.

[9]  Richard D Riley,et al.  Meta‐analysis of continuous outcomes combining individual patient data and aggregate data , 2008, Statistics in medicine.

[10]  Richard D Riley,et al.  Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. , 2007, Journal of clinical epidemiology.

[11]  Mark R. Trusheim,et al.  Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers , 2007, Nature Reviews Drug Discovery.

[12]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[13]  Ewout W Steyerberg,et al.  Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power? , 2006, Annals of epidemiology.

[14]  Keith R Abrams,et al.  Meta‐analysis of heterogeneously reported trials assessing change from baseline , 2005, Statistics in medicine.

[15]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[16]  Mark C Simmonds,et al.  Meta-analysis of individual patient data from randomized trials: a review of methods used in practice , 2005, Clinical trials.

[17]  Paula R Williamson,et al.  Investigating heterogeneity in an individual patient data meta‐analysis of time to event outcomes , 2005, Statistics in medicine.

[18]  K. Gelmon,et al.  The 2000 EBCTCG overview: a widening gap , 2005, The Lancet.

[19]  François Gueyffier,et al.  Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome , 2005, Hypertension.

[20]  Simon G Thompson,et al.  Can meta-analysis help target interventions at individuals most likely to benefit? , 2005, The Lancet.

[21]  A. Grant,et al.  Value of updating a systematic review in surgery using individual patient data , 2004, The British journal of surgery.

[22]  Patrick Royston,et al.  Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancer , 2004, Statistics in medicine.

[23]  John P A Ioannidis,et al.  Commentary: meta-analysis of individual participants' data in genetic epidemiology. , 2002, American journal of epidemiology.

[24]  L. Stewart,et al.  To IPD or not to IPD? , 2002, Evaluation & the health professions.

[25]  Harold I Feldman,et al.  Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head , 2002, Statistics in medicine.

[26]  N. Brünner,et al.  Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. , 2002, Journal of the National Cancer Institute.

[27]  P C Lambert,et al.  A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. , 2002, Journal of clinical epidemiology.

[28]  D. Altman,et al.  Analysing controlled trials with baseline and follow up measurements , 2001, BMJ : British Medical Journal.

[29]  A Whitehead,et al.  Meta‐analysis of ordinal outcomes using individual patient data , 2001, Statistics in medicine.

[30]  A Whitehead,et al.  Meta‐analysis of continuous outcome data from individual patients , 2001, Statistics in medicine.

[31]  D J Hutchon,et al.  Publishing raw data and real time statistical analysis on e-journals , 2001, BMJ : British Medical Journal.

[32]  H Goldstein,et al.  A multilevel model framework for meta-analysis of clinical trials with binary outcomes. , 2000, Statistics in medicine.

[33]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[34]  T. Mathew,et al.  On the Equivalence of Meta‐Analysis Using Literature and Using Individual Patient Data , 1999, Biometrics.

[35]  I Olkin,et al.  Comparison of meta-analysis versus analysis of variance of individual patient data. , 1998, Biometrics.

[36]  George Davey Smith,et al.  Meta-analysis: Beyond the grand mean? , 1997, BMJ.

[37]  L. Stewart,et al.  Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. , 1995, Statistics in medicine.

[38]  L F Burmeister,et al.  A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. , 1995, JAMA.

[39]  L. Stewart,et al.  From science to practice. Meta-analyses using individual patient data are needed. , 1995 .

[40]  M. Parmar,et al.  Meta-analysis of the literature or of individual patient data: is there a difference? , 1993, The Lancet.

[41]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.